Goodwin Procter LLP advised Valo Health on the deal, while Latham & Watkins LLP represented Khosla Ventures Acquisition Co. Valo Health announced its definitive merger agreement with...
Valo Health’s $2.8 Billion Merger with Khosla Ventures Acquisition Co.
Valo Health’s $300 Million Million Series B Funding Round
Goodwin Procter LLP advised Valo Health on the deal. Valo Health announced the final closing of its Series B at $300 million, including a $110 million...